S SHACKELFORD PHARMA

What this means for you

Not registered yet, but its 07 Oct 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

97063826

Mark type

Design + words

Filed

07 Oct 2021

Attorney of record

Steve Zemanick

Goods and services

• Class 005 — Pharmaceuticals: (Based on Intent To Use) Pharmaceutical preparations for treating neurological diseases and disorders; pharmaceutical preparations for treating headaches, neurodegeneration, neurogenesis, epilepsy, childhood epilepsy, paediatric encephalopathies, pain, cancer, managing the effects of chemotherapy, Tourette Syndrome, post-traumatic stress disorder (PTSD), nausea, vomiting, premenstrual syndrome (PMS), neurologic conditions, sleep disorders, cognitive decline, facial pain, spasms, gastrointestinal diseases, rare diseases, Alzheimer's disease, appetite loss, cancer, Crohn's disease, anorexia, bulimia, epilepsy, glaucoma, schizophrenia, multiple sclerosis, muscle spasms, nausea, pain, headaches, wasting syndrome (cachexia), and diseases classified as "orphan" by the US Food and Drug Administration
• Class 035 — Advertising and business services: (Based on 44(d) Priority Application) (Based on Intent to Use) Providing consumer, business and industry information to the public in the fields of medical cannabis, the treatment of medical conditions, and research in the field of medical marijuana
• Class 042 — Scientific and technological services: (Based on 44(d) Priority Application) (Based on Intent to Use) Providing information to the public in the field of scientific and medical research in the field of medical marijuana; Providing information to the public in the field of scientific and medical research in the field of neurological diseases and disorders

Owner

• Shackelford Pharma Inc., British Columbia, CA

Prosecution history

• 25 Aug 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
• 25 Aug 2025 — LETTER OF SUSPENSION E-MAILED
• 25 Aug 2025 — SUSPENSION LETTER WRITTEN
• 25 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 25 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 22 Aug 2025 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
• 11 Jun 2025 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
• 11 Jun 2025 — INQUIRY TO SUSPENSION E-MAILED
• 11 Jun 2025 — SUSPENSION INQUIRY WRITTEN
• 23 May 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
• 22 Nov 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
• 22 Nov 2024 — LETTER OF SUSPENSION E-MAILED
• 22 Nov 2024 — SUSPENSION LETTER WRITTEN
• 18 Nov 2024 — ASSIGNED TO EXAMINER
• 15 Nov 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED